NAD+ or SS-31 improved mitochondrial repair and oxidative resilience
Significant results (8-10% loss) become evident around week 12 as you reach therapeutic doses
However, because compounded products are not FDA-approved as finished products, your provider should monitor you closely and document clinical effectiveness
Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, et al
A 90 day study in 29 participants found improvements in lash length (10.52%), volume (9.3%), thickness (35%), and curl (50.83%) with no adverse reactions reported
Other clinical indications for ALC supplementation include poor sperm motility, male infertility, Peyronies disease, cerebral ischemia and insulin resistance